Skip to main content
KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc. — Investor Relations & Filings

Ticker · KRMD ISIN · US7599101026 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2024-09-30 Director's Dealing
Country US United States of America
Listing US KRMD

About KORU Medical Systems, Inc.

https://www.korumedical.com/

KORU Medical Systems is a medical technology company that designs, develops, manufactures, and commercializes subcutaneous infusion solutions. The company's primary offering is the Freedom™ Infusion System, which includes syringe infusion pumps and related accessories. These systems are engineered for the delivery of large-volume subcutaneous drugs, such as immunoglobulins, to treat patients with chronic illnesses. KORU Medical Systems focuses on providing patient-centric solutions that facilitate safe and effective home-based infusion therapy, aiming to enhance patient quality of life by offering greater freedom and flexibility in treatment management.

Recent filings

Filing Released Lang Actions
FORM 4 FOR 08-15-2024
Director's Dealing
2024-09-30 English
FORM 4 FOR 08-15-2024
Director's Dealing
2024-09-30 English
FORM 8-K CURRENT REPORT FOR 08-15-2024
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 15, 2024, by KORU Medical Systems, Inc. The key content is the announcement of a Long-Term Incentive Program (LTIP) approved by the Compensation Committee of the Board of Directors, including awards to executive officers. It details the structure of the LTIP, types of awards (RSUs, PSUs, Options), vesting schedules, and performance criteria. It also includes a salary increase for a named executive officer. The document is primarily about changes in executive compensation and the approval of a new incentive program by the Board's Compensation Committee. This fits the category of Board/Management Information (MANG), as it announces changes related to senior management compensation and incentive arrangements. It is not a full financial report, earnings release, or proxy statement, but a regulatory filing announcing management-related decisions. The document length and detail confirm it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is MANG with high confidence.
2024-08-21 English
FORM 8-K CURRENT REPORT FOR 08-07-2024
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 7, 2024, reporting the results of operations and financial condition for the fiscal quarter ended June 30, 2024. It references a press release and a conference call about quarterly financial results. The document includes non-GAAP financial measures and a reconciliation exhibit. The content is typical of an Earnings Release announcement rather than a full quarterly report or detailed financial statements. The document length is about 5915 characters, which is consistent with an earnings release or current report rather than a full interim report. Therefore, the filing is best classified as an Earnings Release (ER).
2024-08-07 English
FORM 10-Q QUARTERLY REPORT FOR 06-30-2024
Interim / Quarterly Report Q2 2024
2024-08-07 English
FORM 3 FOR 07-18-2024
Director's Dealing
2024-07-31 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.